References
- Fanaroff JM, Gilbert MI. Neonatology and the law. NeoReviews 2008;9:e24–28.
- American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297–316.
- National Institute of Health and Clinical Excellence (NICE), Neonatal jaundice (CG98). Available at: http://www.nice.org.uk/CG98.
- Capasso L, Parrella C, Borrelli AC, Maffucci R, Milite P, Sodano A, Ferrara T, Raimondi F. Is it worthwhile using a transcutaneous bilirubinometer in the nursery? Early Hum Dev 2012;88 Suppl 2:S25–S26.
- Field MJ, Lohr KN, editors. Guidelines for Clinical Practice: from development to use. Washington, DC, USA: Institute of Medicine, National Academy Press; 1992.
- Diijk PH, Huzelbos CV. An evidence-based view on hyperbilirubinemia. Acta Paediatr Suppl Apr 2012;101:3–10.
- Raimondi F, Indrio F, Crivaro V, Araimo G, Capasso L, Paludetto R. Neonatal hyperbilirubinemia increases intestinal protein permeability and the prevalence of cow’s milk protein intolerance. Acta Paediatr 2008;97:751–753.
- Indrio F, Raimondi F, Laforgia N, Riezzo G, Polimeno L, Francavilla R. Effect of hyperbilirubinemia on intestinal permeability in healthy term newborns. Acta Paediatr 2007;96:73–75.
- Palmela I, Sasaki H, Cardoso FL, Moutinho M, Kim KS, Brites D, Brito MA. Time-dependent dual effects of high levels of unconjugated bilirubin on the human blood-brain barrier lining. Front Cell Neurosci 2012;6:22.
- Raimondi F, Crivaro V, Capasso L, Maiuri L, Santoro P, Tucci M, Barone MV, et al. Unconjugated bilirubin modulates the intestinal epithelial barrier function in a human-derived in vitro model. Pediatr Res 2006;60:30–33.